CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Luye Pharma Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Luye Pharma Group Ltd
No.15 Chuangye Road, High-Tech Zone
Phone: +86 5356717618p:+86 5356717618 YANTAI, SDG  264003  China Ticker: 21862186
Business Summary
Luye Pharma Group Ltd is a company mainly engaged in developing, producing, marketing and selling pharmaceutical products. The Company operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer Dian BoLiu 58 6/8/2016 7/9/2003
Executive Vice Chairman of the Board Rong BingYang 58 3/30/2015 7/9/2003
Chief Financial Officer Yuan ChongLiu 60 1/1/2012 1/1/2012
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Luye Boston R&D LLC 19 PRESIDENTIAL WAY WOBURN MA
Luye Pharma (USA) Ltd. 502 CARNEGIE CTR STE 103 PRINCETON NJ United States

Business Names
Business Name
2186
AsiaPharm Group Ltd.
LUP
Luye Pharma Group Ltd

General Information
Number of Employees: 5,234 (As of 6/30/2024)
Outstanding Shares: 3,761,670,643 (As of 6/30/2024)
Shareholders: 581
Stock Exchange: HKG
Fax Number: +86 5356717718


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025